Motley Fool rips apart Intrexon and Amyris

In New York, Motley Fool has come out hitting hard at Intrexon and Amyris, convinced that the latter is on its way to a slow death and the former, that despite trying its hardest to not repeat the mistakes Amyris made, has instead made others that have basically sentenced it to death as well. Perhaps a faster one. The main criticism is that despite Intrexon hitting many of its milestones early on, its path to commercialization appears to be unachievable and therefore likely to upset investors to the point of abandonment.

Amyris,: The Digest’s 2015 5 Minute Guide